These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 1834712

  • 1. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
    Akamatsu H, Nishijima S, Takahashi M, Ushijima T, Asada Y.
    J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712
    [Abstract] [Full Text] [Related]

  • 2. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin.
    Webster GF, Leyden JJ, McGinley KJ, McArthur WP.
    Antimicrob Agents Chemother; 1982 May; 21(5):770-2. PubMed ID: 7049078
    [Abstract] [Full Text] [Related]

  • 3. Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism.
    Akamatsu H, Niwa Y, Kurokawa I, Masuda R, Nishijima S, Asada Y.
    Arch Dermatol Res; 1991 May; 283(8):524-8. PubMed ID: 1838472
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of neutrophil chemotactic factor production in comedonal bacteria by subminimal inhibitory concentrations of erythromycin.
    Akamatsu H, Kurokawa I, Nishijima S, Asada Y.
    Dermatology; 1992 May; 185(1):41-3. PubMed ID: 1386264
    [Abstract] [Full Text] [Related]

  • 5. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils.
    Jain A, Sangal L, Basal E, Kaushal GP, Agarwal SK.
    Dermatol Online J; 2002 Oct; 8(2):2. PubMed ID: 12546757
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I, Nishijima S, Kawabata S.
    Eur J Dermatol; 1999 Oct; 9(1):25-8. PubMed ID: 9920982
    [Abstract] [Full Text] [Related]

  • 7. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
    Nishijima S, Akamatsu H, Akamatsu M, Kurokawa I, Asada Y.
    J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
    [Abstract] [Full Text] [Related]

  • 8. Resistance of propionibacteria to antibiotics used in the treatment of acne.
    Brown JM, Poston SM.
    J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
    [Abstract] [Full Text] [Related]

  • 9. Propionibacterium acnes biotypes and susceptibility to minocycline and Keigai-rengyo-to.
    Higaki S, Nakamura M, Morohashi M, Yamagishi T.
    Int J Dermatol; 2004 Feb; 43(2):103-7. PubMed ID: 15125499
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M, Wasik B, Becker A, Höffler U.
    Dermatology; 2002 Feb; 205(3):260-4. PubMed ID: 12399674
    [Abstract] [Full Text] [Related]

  • 11. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M, Seo SH, Ko HC, Oh CK, Kwon KS, Chang CL, Kim MB.
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
    Schafer F, Fich F, Lam M, Gárate C, Wozniak A, Garcia P.
    Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
    Luk NM, Hui M, Lee HC, Fu LH, Liu ZH, Lam LY, Eastel M, Chan YK, Tang LS, Cheng TS, Siu FY, Ng SC, Lai YK, Ho KM.
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
    [Abstract] [Full Text] [Related]

  • 14. Propionibacterium acnes resistance to antibiotics in acne patients.
    Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM.
    J Am Acad Dermatol; 1983 Jan; 8(1):41-5. PubMed ID: 6219134
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
    Ergin C, Ergin S, Kaleli I, Kaçar N, Sengül M, Erdoğan BS.
    J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100
    [No Abstract] [Full Text] [Related]

  • 17. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L, Papaparaskevas J, Refene E, Daikos G, Stavrianeas N, Tsakris A.
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [Abstract] [Full Text] [Related]

  • 18. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore.
    Tan HH, Goh CL, Yeo MG, Tan ML.
    Ann Acad Med Singap; 2001 Jan; 30(1):22-5. PubMed ID: 11242619
    [Abstract] [Full Text] [Related]

  • 19. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S, Kurokawa I, Katoh N, Watanabe K.
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [Abstract] [Full Text] [Related]

  • 20. Relationship between Propionibacterium acnes biotypes and Jumi-haidoku-to.
    Higaki S, Kitagawa T, Kagoura M, Morohashi M, Yamagishi T.
    J Dermatol; 2000 Oct; 27(10):635-8. PubMed ID: 11092266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.